Acción ISLE ISLEWORTH HEALTHCARE ACQUISITION CORP.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate
Instrumento Inactivo

Otros idiomas Isleworth Healthcare Acquisition Corp.

Acciones

ISLE

US46468P1021

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
ISLEWORTH HEALTHCARE ACQUISITION CORP. : Other Events, Financial Statements and Exhibits (form 8-K)
Isleworth Healthcare Acquisition to Dissolve, Delist After Failing to Combine Business by Sept. 1
Isleworth Healthcare Acquisition Corp.(NasdaqCM:ISLE) dropped from NASDAQ Composite Index
Isleworth Healthcare Acquisition Corp. Announces Cancellation of Special Meeting of Shareholders, Redemption of Public Shares and Subsequent Dissolution
ISLEWORTH HEALTHCARE ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Isleworth Healthcare Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Blank Check Firm Isleworth Healthcare Acquisition, Cytovia Scrap Merger Deal
ISLEWORTH AND CYTOVIA TERMINATE MERGER AGREEMENT
Isleworth Healthcare Acquisition : AND CYTOVIA TERMINATE MERGER AGREEMENT - Form 8-K
ISLEWORTH HEALTHCARE ACQUISITION CORP. : Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)
Cytovia Therapeutics, Inc. cancelled the acquisition of Isleworth Healthcare Acquisition Corp. from Isleworth Healthcare Sponsor I, LLC and others in a reverse merger transaction.
ISLEWORTH HEALTHCARE ACQUISITION CORP. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
ISLEWORTH HEALTHCARE ACQUISITION CORP. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
Cytovia Therapeutics presents antitumor activity of its CD38-Targeting Flex-NK™ Cell Engager antibody at EHA 2022 Congress
Isleworth Healthcare Acquisition : Cytovia Therapeutics Appoints Luca Scavo as Chief Financial Officer and James Priour as Chief Product Officer - Form 8-K
ISLEWORTH HEALTHCARE ACQUISITION CORP. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
Isleworth Healthcare Acquisition : Quarterly Report (Form 10-Q)
Isleworth Healthcare Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022
ISLEWORTH HEALTHCARE ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Cytovia Therapeutics to Present In Vivo Multiple Myeloma Data of its CD38-Targeting Flex-NK™ Cell Engager at EHA 2022 Congress
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción ISLE
  4. Noticias Isleworth Healthcare Acquisition Corp.
  5. Otros idiomas